Search research articles
Contact Us
Filters
Showing results (211-220 of 314) with videos related to
Page
of 32
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
Arnaud D Roth, Nicola Fazio, Roger Stupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study
Panagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Oncotarget
|
February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
Michael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Oncoimmunology
|
February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Florian Posch, Karina Silina, Sebastian Leibl, et al.
Acta Neuropathologica
|
July 20, 2012
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
Pierre Bady, Davide Sciuscio, Annie-Claire Diserens, et al.
Neuro-Oncology
|
November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas
Michael R Drumm, Karan S Dixit, Sean Grimm, et al.
Cancer Research
|
April 22, 2011
Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors
Julien Laurent, Eveline Faes-van't Hull, Cedric Touvrey, et al.
Neuro-Oncology
|
December 26, 2022
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033
Johan M Kros, Elisabeth Rushing, Aimé L Uwimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations
Daniel Y Zhang, Crismita Dmello, Li Chen, et al.
Page
of 32
Search research articles
Search
Showing results (211-220 of 314) with videos related to
Sort By:
Page
of 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 2007
Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research
Arnaud D Roth, Nicola Fazio, Roger Stupp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 29, 2017
Infiltrating T Cells Increase IDO1 Expression in Glioblastoma and Contribute to Decreased Patient Survival
Lijie Zhai, Erik Ladomersky, Kristen L Lauing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 17, 2017
Mobilization of Hematopoietic Progenitor Cells with Standard- or Reduced-Dose Filgrastim after Vinorelbine in Multiple Myeloma Patients: A Randomized Prospective Single-Center Phase II Study
Panagiotis Samaras, Markus F Rütti, Burkhardt Seifert, et al.
Oncotarget
|
February 27, 2016
Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
Michael Weller, Louis Burt Nabors, Thierry Gorlia, et al.
Oncoimmunology
|
February 9, 2018
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Florian Posch, Karina Silina, Sebastian Leibl, et al.
Acta Neuropathologica
|
July 20, 2012
MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
Pierre Bady, Davide Sciuscio, Annie-Claire Diserens, et al.
Neuro-Oncology
|
November 12, 2019
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas
Michael R Drumm, Karan S Dixit, Sean Grimm, et al.
Cancer Research
|
April 22, 2011
Proangiogenic factor PlGF programs CD11b(+) myelomonocytes in breast cancer during differentiation of their hematopoietic progenitors
Julien Laurent, Eveline Faes-van't Hull, Cedric Touvrey, et al.
Neuro-Oncology
|
December 26, 2022
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033
Johan M Kros, Elisabeth Rushing, Aimé L Uwimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 14, 2019
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations
Daniel Y Zhang, Crismita Dmello, Li Chen, et al.
Page
of 32